HINXTON HALL LIMITED
Get an alert when HINXTON HALL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-06-30 (in 1y)
Last filed for 2025-09-30
Confirmation statement due
2027-05-11 (in 1y)
Last made up 2026-04-27
Watchouts
None on the register
Cash
£1M
-19.2% vs 2024
Net assets
£25M
-24.9% vs 2024
Employees
0
Average over period
Profit before tax
—
Period ending 2025-09-30
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-09-30
| Metric | Trend | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Turnover | £29,061,000 | £21,215,000 | |
| Operating profit | — | — | |
| Profit before tax | — | — | |
| Net profit | -£709,000 | -£436,000 | |
| Cash | £1,328,000 | £1,073,000 | |
| Total assets less current liabilities | £33,668,000 | £25,284,000 | |
| Net assets | £33,668,000 | £25,284,000 | |
| Equity | £33,668,000 | £25,284,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Net margin | -2.4% | -2.1% | |
| Current ratio | 0.97x | 0.94x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Therefore, the Trustees are satisfied that it is appropriate to adopt the going concern basis in preparing the financial statements.”
Significant events
- “Responsibility for providing facilities management services to the Wellcome Genome Campus transferred to another company, Wellcome Genome Campus Limited, in February 2025. Conference facilities and activities remain with the Company and are expected to transfer after 31 December 2026.”
- “The head lease and sublease were varied so as to leave only the properties occupied by GRL and HHL respectively. The buildings and plant surrendered to the Wellcome Trust were sold at market value, resulting in a loss on disposal of £7.9 million.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MELITI, Nadia | Secretary | 2019-05-07 | — | — |
| MOORE, Simon David | Director | 2025-01-24 | Jul 1965 | British |
| RYEN, Jeffrey | Director | 2024-12-13 | Jul 1966 | American |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAYTER, Dianne | Secretary | 1998-06-17 | 1999-07-30 |
| KHAN, Sabien | Secretary | 2012-02-01 | 2015-12-18 |
| PARKINSON, Henry | Secretary | 2015-12-18 | 2019-05-07 |
| STEWART, John Gillespie | Secretary | 1999-07-30 | 2012-01-31 |
| STEWART, John Gillespie | Secretary | 1995-07-11 | 1998-06-17 |
| CMH SECRETARIES LIMITED | Corporate Nominee Secretary | 1995-05-23 | 1995-07-11 |
| BRADLEY, Allan, Dr | Director | 2001-04-23 | 2005-03-16 |
| COOPER, John | Director | 1999-10-15 | 2013-02-17 |
| DAVISON, David Neil | Director | 2005-03-16 | 2014-04-30 |
| DODD, Barton Charles | Director | 1995-07-11 | 1998-06-08 |
| DOUGHERTY, Martin James, Dr | Director | 2014-05-01 | 2024-10-31 |
| GIBSON, Keith Ivan, Dr | Director | 1998-06-09 | 2002-10-18 |
| KIFF, Genevieve | Director | 2015-09-16 | 2018-10-30 |
| KIFF, Genny | Director | 2006-05-04 | 2013-02-17 |
| MASSON, Stephen Clark | Director | 2013-02-18 | 2015-09-16 |
| MEREDITH, Graham, Captain | Director | 1998-06-09 | 1999-10-15 |
| MORETON, Kevin, Dr | Director | 2013-02-18 | 2015-04-02 |
| MORGAN, Michael James | Director | 1995-07-11 | 2002-10-18 |
| PAYNE, Margaret Susan | Director | 2018-10-30 | 2024-12-13 |
| PHILLIPPS, David Alan | Director | 2002-10-18 | 2006-05-04 |
| CMH DIRECTORS LIMITED | Corporate Nominee Director | 1995-05-23 | 1995-07-11 |
| CMH SECRETARIES LIMITED | Corporate Nominee Director | 1995-05-23 | 1995-07-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Genome Research Limited | Corporate entity | Voting 50–75% | 2016-04-06 | Active |
| The Wellcome Trust Limited | Corporate entity | Voting 50–75%, right-to-appoint-and-remove-directors-as-trust, significant-influence-or-control-as-trust | 2016-04-06 | Active |
Filing timeline
Last 20 of 136 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-03-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | AA | accounts | Accounts with accounts type full | |
| 2024-12-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-06-25 | AA | accounts | Accounts with accounts type full | |
| 2024-06-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-06-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-05-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-10 | AA | accounts | Accounts with accounts type full | |
| 2022-06-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-28 | AA | accounts | Accounts with accounts type full | |
| 2021-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-03-22 | AA | accounts | Accounts with accounts type full | |
| 2020-06-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-01-14 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-09-30 vs 2024-09-30
-
Turnover
-27%
£29,061,000 £21,215,000
-
Cash
-19.2%
£1,328,000 £1,073,000
-
Net assets
-24.9%
£33,668,000 £25,284,000
-
Employees
—
Not reported
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers